MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness items, such as prescription medicines, over-the-counter drugs, vitamins, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers.
MedPlus Health Services Limited (MEDPLUS) is listed on the NSE in the Healthcare sector, Pharmaceutical Retailers industry. The MEDPLUS share price is ₹604.05 (-0.09% today), with a market capitalisation of ₹73B and a price-to-earnings (P/E) ratio of 34.7. MarketRipple tracks the MEDPLUS investment thesis, the ripple-chain impact of market events on MedPlus Health Services Limited, and the Healthcare sector outlook.
Open
₹617.00
High
₹617.00
Low
₹602.95
Prev. Close
₹604.60
52W High
₹1,022.20
52W Low
₹565.60
Day range
₹602.95–₹617.00
52-week range
₹565.60–₹1,022.20
Volume
57K
P/E
34.7
ROE
10.8%
D/E
0.72
Margin
2.8%
MedPlus Health Services Limited (NSE: MEDPLUS) is currently trading at ₹604.05 (-0.09%).
MedPlus Health Services Limited's market capitalization is ₹73B.
MedPlus Health Services Limited's price-to-earnings (P/E) ratio is 34.7.
MedPlus Health Services Limited operates in the Healthcare sector (Pharmaceutical Retailers).
Analyst consensus on MedPlus Health Services Limited currently reads strongly positive, based on 7 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.